ICU Medical, Incorporated (NASDAQ:ICUI)’s share price was up 8.7% on Thursday . The company traded as high as $245.12 and last traded at $243.96. Approximately 845,630 shares traded hands during trading, an increase of 394% from the average daily volume of 171,065 shares. The stock had previously closed at $224.50.

A number of equities analysts have weighed in on ICUI shares. TheStreet raised ICU Medical from a “c+” rating to a “b+” rating in a research report on Monday, August 20th. ValuEngine downgraded ICU Medical from a “strong-buy” rating to a “buy” rating in a research report on Friday, August 3rd. BidaskClub raised ICU Medical from a “hold” rating to a “buy” rating in a research report on Friday, September 28th. Finally, Zacks Investment Research downgraded ICU Medical from a “strong-buy” rating to a “hold” rating in a research report on Thursday, October 11th.

The firm has a market cap of $4.49 billion, a P/E ratio of 44.20 and a beta of 0.65.

ICU Medical (NASDAQ:ICUI) last released its quarterly earnings data on Thursday, November 8th. The medical instruments supplier reported $1.85 EPS for the quarter, beating the consensus estimate of $1.51 by $0.34. The company had revenue of $327.20 million during the quarter, compared to the consensus estimate of $334.97 million. ICU Medical had a return on equity of 15.20% and a net margin of 6.00%. The firm’s revenue for the quarter was down 4.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.12 EPS. On average, sell-side analysts anticipate that ICU Medical, Incorporated will post 7.6 EPS for the current year.

In related news, VP Virginia Ruth Sanzone sold 787 shares of the stock in a transaction on Tuesday, August 28th. The stock was sold at an average price of $303.12, for a total value of $238,555.44. Following the sale, the vice president now owns 1,367 shares in the company, valued at approximately $414,365.04. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, VP Thomas D. Mccall sold 11,133 shares of the stock in a transaction on Friday, August 24th. The shares were sold at an average price of $302.56, for a total value of $3,368,400.48. Following the completion of the sale, the vice president now owns 3,018 shares in the company, valued at approximately $913,126.08. The disclosure for this sale can be found here. Corporate insiders own 12.50% of the company’s stock.

A number of institutional investors and hedge funds have recently bought and sold shares of ICUI. LPL Financial LLC bought a new stake in ICU Medical in the 1st quarter valued at $218,000. State of Alaska Department of Revenue bought a new stake in ICU Medical in the 2nd quarter valued at $554,000. Xact Kapitalforvaltning AB raised its stake in ICU Medical by 18.4% in the 2nd quarter. Xact Kapitalforvaltning AB now owns 2,572 shares of the medical instruments supplier’s stock valued at $755,000 after acquiring an additional 400 shares during the period. Campbell & CO Investment Adviser LLC bought a new stake in ICU Medical in the 2nd quarter valued at $230,000. Finally, Retirement Systems of Alabama raised its stake in ICU Medical by 1.1% in the 2nd quarter. Retirement Systems of Alabama now owns 19,732 shares of the medical instruments supplier’s stock valued at $5,794,000 after acquiring an additional 206 shares during the period. Institutional investors and hedge funds own 74.50% of the company’s stock.

WARNING: This piece was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece on another domain, it was illegally copied and reposted in violation of United States and international copyright and trademark legislation. The correct version of this piece can be accessed at https://www.thecerbatgem.com/2018/11/15/icu-medical-icui-trading-up-8-7.html.

ICU Medical Company Profile (NASDAQ:ICUI)

ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.

Recommended Story: Correction

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.